A reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid disease

Bibliographic Details
Main Authors: Steven M. Johnson, James Haberberger, Jonathan Galeotti, Lori Ramkissoon, Catherine C. Coombs, Daniel R. Richardson, Matthew C. Foster, Daniel Duncan, Joshua F. Zeidner, Naomi L. Ferguson, Nathan D. Montgomery
Format: Article
Language:English
Published: Nature Publishing Group 2023-06-01
Series:Blood Cancer Journal
Online Access:https://doi.org/10.1038/s41408-023-00876-w
_version_ 1797789888570982400
author Steven M. Johnson
James Haberberger
Jonathan Galeotti
Lori Ramkissoon
Catherine C. Coombs
Daniel R. Richardson
Matthew C. Foster
Daniel Duncan
Joshua F. Zeidner
Naomi L. Ferguson
Nathan D. Montgomery
author_facet Steven M. Johnson
James Haberberger
Jonathan Galeotti
Lori Ramkissoon
Catherine C. Coombs
Daniel R. Richardson
Matthew C. Foster
Daniel Duncan
Joshua F. Zeidner
Naomi L. Ferguson
Nathan D. Montgomery
author_sort Steven M. Johnson
collection DOAJ
first_indexed 2024-03-13T01:57:00Z
format Article
id doaj.art-0205bf92f623489f8f3ab8c60ddb2fb6
institution Directory Open Access Journal
issn 2044-5385
language English
last_indexed 2024-03-13T01:57:00Z
publishDate 2023-06-01
publisher Nature Publishing Group
record_format Article
series Blood Cancer Journal
spelling doaj.art-0205bf92f623489f8f3ab8c60ddb2fb62023-07-02T11:08:04ZengNature Publishing GroupBlood Cancer Journal2044-53852023-06-011311410.1038/s41408-023-00876-wA reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid diseaseSteven M. Johnson0James Haberberger1Jonathan Galeotti2Lori Ramkissoon3Catherine C. Coombs4Daniel R. Richardson5Matthew C. Foster6Daniel Duncan7Joshua F. Zeidner8Naomi L. Ferguson9Nathan D. Montgomery10Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill School of MedicineFoundation Medicine, IncDepartment of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill School of MedicineDepartment of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill School of MedicineDivision of Hematology, Department of Medicine, The University of North Carolina at Chapel Hill School of MedicineDivision of Hematology, Department of Medicine, The University of North Carolina at Chapel Hill School of MedicineDivision of Hematology, Department of Medicine, The University of North Carolina at Chapel Hill School of MedicineFoundation Medicine, IncDivision of Hematology, Department of Medicine, The University of North Carolina at Chapel Hill School of MedicineFoundation Medicine, IncDepartment of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill School of Medicinehttps://doi.org/10.1038/s41408-023-00876-w
spellingShingle Steven M. Johnson
James Haberberger
Jonathan Galeotti
Lori Ramkissoon
Catherine C. Coombs
Daniel R. Richardson
Matthew C. Foster
Daniel Duncan
Joshua F. Zeidner
Naomi L. Ferguson
Nathan D. Montgomery
A reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid disease
Blood Cancer Journal
title A reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid disease
title_full A reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid disease
title_fullStr A reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid disease
title_full_unstemmed A reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid disease
title_short A reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid disease
title_sort reappraisal of asxl1 mutation sites and the cohesin binding motif in myeloid disease
url https://doi.org/10.1038/s41408-023-00876-w
work_keys_str_mv AT stevenmjohnson areappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease
AT jameshaberberger areappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease
AT jonathangaleotti areappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease
AT loriramkissoon areappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease
AT catherineccoombs areappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease
AT danielrrichardson areappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease
AT matthewcfoster areappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease
AT danielduncan areappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease
AT joshuafzeidner areappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease
AT naomilferguson areappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease
AT nathandmontgomery areappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease
AT stevenmjohnson reappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease
AT jameshaberberger reappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease
AT jonathangaleotti reappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease
AT loriramkissoon reappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease
AT catherineccoombs reappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease
AT danielrrichardson reappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease
AT matthewcfoster reappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease
AT danielduncan reappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease
AT joshuafzeidner reappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease
AT naomilferguson reappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease
AT nathandmontgomery reappraisalofasxl1mutationsitesandthecohesinbindingmotifinmyeloiddisease